Arquivamento definitivo - Art. 33 da LPI
#11.1.1
01/17/2023
RPI 2715
Back to search
Official data from INPI
ANTICORPOS AGONISTAS DE CD226
ArquivadaInvention PatentPCT · US2019042604
Application data
Number
112020027087Type
Invention Patent
Filing
07/19/2019
Publication
03/30/2021
PCT
US2019042604 Progress at the INPI
- Filing07/19/19
- Publication03/30/21
- Abandoned
- Allowance
- Grant
- In force
The application was abandoned: examination was not requested within the 36 months following the 07/19/2019 filing, the deadline set by art. 33 of the Brazilian IP Act. The technology is in the public domain in Brazil.
Talk to a specialistLatest action published by the INPI: 01/17/2023. We update with every new RPI gazette, published weekly.
Applicants and inventors
Applicants
ELI LILLY AND COMPANY
US
Inventors
N. K. (pessoa física)
US
Technical data
IPC Classification
Priority claims
US
62/703,522 · 07/26/2018
US
62/795,744 · 01/23/2019
Abstract
A presente invenção refere-se a anticorpos agonistas anti-CD226 humano, os quais podem ser úteis para tratar cânceres de tumor sólido.
Prosecution history
Publications in the Brazilian Industrial Property Gazette (RPI).
Arquivamento - Art. 33 da LPI
#11.1
11/01/2022
RPI 2704
Notificação de entrada na fase nacional - PCT
#1.3
03/30/2021
RPI 2621
Alteração de dados cadastrais
#1.1
01/12/2021
RPI 2610
Related
From the same holder
Same category
202026014579SISTEMA PANTOGRÁFICO PREDITIVO DE AJUSTE AUTOMÁTICO DE PROFUNDIDADE PARA IMPLEMENTO AGRÍCOLA DE DESCOMPACTAÇÃO DO SOLO102026013520102026013212102026012256DISPOSITIVO PORTÁTIL DE TREINAMENTO ENDODÔNTICO E MÉTODO DE EXECUÇÃO DE PROCEDIMENTOS ENDODÔNTICOS SIMULADOSCONJUNTO ESPONJA MODULARDISPOSIÇÃO INTRODUZIDA EM ELETRODO BIPOLAR PARA RESSECÇÃO
Patent monitoring
Track this patent in real time.
Receive alerts on INPI events, decisions, and expiry dates for your portfolio.